Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of Ashley Davison
Introduction
Ashley Davison is a notable inventor based in Belfast, Antrim, GB. He has made significant contributions to the field of biotechnology, particularly in the development of novel peptides for therapeutic applications. With a total of 3 patents to his name, Davison's work is paving the way for advancements in drug delivery systems.
Latest Patents
One of Davison's latest patents focuses on an amphipathic peptide designed for delivering small molecule agents to cells. This innovative peptide comprises fewer than 50 amino acid residues, including at least 6 arginine residues, 12 alanine residues, and 6 leucine residues. The peptide is characterized by a specific ratio of arginine to negatively charged amino acid residues, as well as a defined ratio of hydrophilic to hydrophobic amino acid residues. Additionally, the invention includes a nanoparticle and cell delivery system that utilizes this amphipathic peptide, which can be employed in therapeutic applications, including the delivery of nucleic acids and other small molecules.
Career Highlights
Ashley Davison is affiliated with The Queen's University of Belfast, where he continues to engage in research and development in the field of biotechnology. His work is instrumental in advancing the understanding and application of peptide-based therapies.
Collaborations
Some of his notable coworkers include Helen McCarthy and Aleksey Zholobenko, who contribute to the collaborative research efforts at the university.
Conclusion
Ashley Davison's innovative work in peptide technology and drug delivery systems exemplifies the potential of biotechnology to transform therapeutic practices. His contributions are significant in the ongoing quest for effective medical solutions.